Honz Pharmaceutical Co., Ltd. (SHE:300086)
China · Delayed Price · Currency is CNY 4.750
-0.110 (-2.26%)
Nov 13, 2026, 3:04 PM CST
Honz Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 5.77 | 59.75 | 113.19 | 145.09 | 270.11 | 258.99 |
Cash & Short-Term Investments | 5.77 | 59.75 | 113.19 | 145.09 | 270.11 | 258.99 |
Cash Growth | -67.85% | -47.21% | -21.99% | -46.28% | 4.29% | -0.02% |
Accounts Receivable | 25.32 | 44.16 | 68.77 | 139.63 | 73.14 | 153.16 |
Other Receivables | 9.24 | 6.38 | 25.92 | 39.26 | 52.59 | 66.3 |
Receivables | 34.56 | 50.54 | 94.7 | 178.89 | 125.73 | 219.45 |
Inventory | 149.7 | 160.12 | 187.33 | 236.43 | 170.4 | 197.87 |
Prepaid Expenses | - | 0.34 | 0.38 | 0.43 | - | - |
Other Current Assets | 30.03 | 33.73 | 47.19 | 48.51 | 104.22 | 43.59 |
Total Current Assets | 220.06 | 304.48 | 442.78 | 609.35 | 670.46 | 719.9 |
Property, Plant & Equipment | 689.94 | 715.17 | 1,022 | 987.29 | 950.53 | 989.88 |
Long-Term Investments | 4.97 | 4.97 | 4.97 | 5.3 | 5.95 | 10.98 |
Goodwill | 8.3 | 8.3 | 13.5 | 20.05 | 18.89 | 18.89 |
Other Intangible Assets | 57.83 | 63.71 | 139.86 | 160.33 | 167.55 | 202.68 |
Long-Term Deferred Tax Assets | 66.02 | 70.74 | 51.59 | 42.3 | 47.9 | 25.94 |
Long-Term Deferred Charges | 54.06 | 55.87 | 77.87 | 81.02 | 75.21 | 72.86 |
Other Long-Term Assets | 565.9 | 567.76 | 223.65 | 259.98 | 351.98 | 417.66 |
Total Assets | 1,667 | 1,791 | 1,976 | 2,166 | 2,288 | 2,459 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 53.33 | 52.71 | 66.26 | 78.02 | 57.4 | 112.33 |
Accrued Expenses | 7.66 | 94.94 | 64.8 | 44.29 | 43.8 | 30.47 |
Short-Term Debt | 195.44 | 166.05 | 171.08 | 139.89 | 133.22 | 148.5 |
Current Portion of Long-Term Debt | 80.24 | 80.57 | 110.51 | 36.77 | 107.05 | 100.78 |
Current Portion of Leases | - | 0.6 | 0.46 | - | - | - |
Current Income Taxes Payable | 10.36 | 3.02 | 3.03 | 16.27 | 3.77 | 4.16 |
Current Unearned Revenue | 12.34 | 24.53 | 42.21 | 10.79 | 95.66 | 26.1 |
Other Current Liabilities | 207.26 | 161.06 | 62.39 | 54.56 | 63.61 | 62.59 |
Total Current Liabilities | 566.63 | 583.49 | 520.74 | 380.59 | 504.51 | 484.92 |
Long-Term Debt | 153.58 | 181.82 | 210 | 324.98 | 342.85 | 343.52 |
Long-Term Leases | 18.23 | 17.66 | 18.65 | - | - | - |
Long-Term Unearned Revenue | 51.67 | 53.89 | 51.63 | 48.18 | 51 | 35.61 |
Long-Term Deferred Tax Liabilities | 32.75 | 32.93 | 34.58 | 33.86 | 34.6 | 41.09 |
Total Liabilities | 822.85 | 869.79 | 835.59 | 787.6 | 932.96 | 905.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 455.12 | 455.12 | 455.12 | 450 | 450 | 450 |
Additional Paid-In Capital | 842.99 | 842.99 | 842.99 | 836.49 | 818.96 | 818.96 |
Retained Earnings | -540.27 | -464.47 | -234.34 | 6.28 | -5.25 | 182.34 |
Comprehensive Income & Other | 66.03 | 66.07 | 51.73 | 51.98 | 52.47 | 52.65 |
Total Common Equity | 823.88 | 899.71 | 1,116 | 1,345 | 1,316 | 1,504 |
Minority Interest | 20.36 | 21.51 | 25.4 | 33.26 | 39.33 | 49.69 |
Shareholders' Equity | 844.24 | 921.22 | 1,141 | 1,378 | 1,356 | 1,554 |
Total Liabilities & Equity | 1,667 | 1,791 | 1,976 | 2,166 | 2,288 | 2,459 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 447.49 | 446.69 | 510.7 | 501.64 | 583.12 | 592.8 |
Net Cash (Debt) | -441.72 | -386.94 | -397.52 | -356.55 | -313.01 | -333.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.97 | -0.85 | -0.88 | -0.79 | -0.70 | -0.74 |
Filing Date Shares Outstanding | 455.12 | 455.12 | 455.12 | 450 | 450 | 450 |
Total Common Shares Outstanding | 455.12 | 455.12 | 455.12 | 450 | 450 | 450 |
Working Capital | -346.57 | -279.01 | -77.95 | 228.76 | 165.95 | 234.98 |
Book Value Per Share | 1.81 | 1.98 | 2.45 | 2.99 | 2.92 | 3.34 |
Tangible Book Value | 757.75 | 827.7 | 962.15 | 1,164 | 1,130 | 1,282 |
Tangible Book Value Per Share | 1.66 | 1.82 | 2.11 | 2.59 | 2.51 | 2.85 |
Buildings | - | 739.95 | 1,054 | 872.16 | 860.84 | 362.09 |
Machinery | - | 403.6 | 398.28 | 383.47 | 381.58 | 289.25 |
Construction In Progress | - | 18 | 12.03 | 145.62 | 59.59 | 659.28 |